PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10681408-3	2000	Recently, we reported that families with FCH and families enriched for coronary artery disease (CAD) share genetic determinants for the atherogenic lipoprotein phenotype (ALP), a profile presenting with small, dense LDL particles, decreased HDL-cholesterol levels, and increased triglyceride levels.	Cholesterol	245-256	ATHS	Homo sapiens	136-169	
17080469-3	2007	Small, dense LDL, with elevated triglyceride levels and low HDL-cholesterol concentrations, constitute the "atherogenic lipoprotein phenotype (ALP)", a form of atherogenic dyslipidemia that is a feature of type 2 diabetes and the metabolic syndrome.	Cholesterol	64-75	ATHS	Homo sapiens	107-141	
17080469-3	2007	Small, dense LDL, with elevated triglyceride levels and low HDL-cholesterol concentrations, constitute the "atherogenic lipoprotein phenotype (ALP)", a form of atherogenic dyslipidemia that is a feature of type 2 diabetes and the metabolic syndrome.	Cholesterol	64-75	ATHS	Homo sapiens	143-146	
10681408-10	2000	Our results provide support that ALP is a multigenic trait and suggest that the relationship between small, dense LDL particles, HDL-cholesterol, and triglyceride levels in FCH families is due, in part, to common genetic factors.	Cholesterol	133-144	ATHS	Homo sapiens	33-36	
10681408-3	2000	Recently, we reported that families with FCH and families enriched for coronary artery disease (CAD) share genetic determinants for the atherogenic lipoprotein phenotype (ALP), a profile presenting with small, dense LDL particles, decreased HDL-cholesterol levels, and increased triglyceride levels.	Cholesterol	245-256	ATHS	Homo sapiens	171-174	
24930071-5	2014	RESULTS: In multiple step-wise regression analysis, the aLp-PLA2 was significantly positively associated with male gender, current smoking, LDL cholesterol and metabolic syndrome and negatively with statin treatment, body mass index and LDL/apoB ratio.	Cholesterol	144-155	ATHS	Homo sapiens	56-59	
22011476-1	2012	Increased plasma concentrations of small LDL particles denote an atherogenic lipoprotein phenotype (ALP) that is correlated with increased circulating TAG and reduced HDL-cholesterol.	Cholesterol	171-182	ATHS	Homo sapiens	100-103	
21475144-6	2011	Gross and net efficiencies were significantly increased (P = 0.005) in ALP(+) vs. ALP(-) at 10 W. RER was correlated positively with plasma triglyceride during exercise and inversely with high-density lipoprotein (HDL) cholesterol and LDL peak particle diameter during rest and exercise (P < 0.05).	Cholesterol	219-230	ATHS	Homo sapiens	71-74	
18524173-2	2008	Characterized by high plasma triglyceride, small dense LDL, and reduced high-density lipoprotein (HDL) cholesterol, an ALP is associated with insulin resistance.	Cholesterol	103-114	ATHS	Homo sapiens	119-122